Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology | Family Medicine
 Disease Category: Depression
Location: United States, CA

Trial Information

Clinical Research Study of an investigational medication for treatment resistant Major Depressive Disorder

A multicenter, randomized, double-blind, phase II, safety and efficacy study of xxx vs standard antidepressant therapy in patients with Major Depressive Disorder who exhibit an inadequate response to antidepressant therapy.

Length of study: up to 22 weeks
Number of office visits: 18 to 22 visits
Qualified participants will receive either an approved antidepressant or an investigational study medication. Participants will receive study related care at no cost and will be compensated for time and travel.

Patient Inclusion Criteria:

  • Patients have to be 18 to 65 years old
  • Read and Understand English
  • Meet criteria for Major Depressive Disorder
  • Are without serious health problems
  • Have a history of inadequate response to 1-3 antidepressants for current depressive episode

Patient Exclusion Criteria:

  • Patients with certain conditions such as Bipolar, Obsessive-Compulsive Disorder, or Schizophrenia
  • Patients with a a recent drug or alcohol abuse history

Schuster Medical Research Institute
5000 Van Nuys Blvd., Suite 216
Sherman Oaks, CA 91403
Phone: (818) 778-0746
Fax: (818) 788-0742

View Map

Research Center Information: Schuster Medical Research Institute

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.